chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme fatigue on day 2 that lasted for a few days, lump in arm at injection site still present after 4 weeks, muscle aches first night, muscle cramps in arms and legs are still present, headache started on day two and lasted a few days.  Chills on day three that lasted a day. Head and sinus congestion that lasted two weeks also dizziness went to emergency room and received antibiotics.  High blood pressure.  Also had low blood sugar for about two days.  Was hard to keep blood sugar level up.
No adverse reaction. Just want to report that a 16 year old received a Moderna Booster. So far not adverse reaction. She should have gotten the Pfizer booster instead.
Headache, Diarrhea, chills, malaise, pain at injection site Narrative: Per nursing report: "c/o took 2nd dose of Moderna vaccine yesterday [6/1] and c/o states severe soreness to left arm, major headache, diarrhea, chills and states just not feeling well."
Approximately 1 hour after pt received Td, Hep A #2, PPD, he started to develop multiple red, itchy macular rash on both cheeks and upper arm. No SOB, wheezing. The rash resolved in 30 minutes after pt was given Benadryl 25 mg IM.
Fading Blood levels rose 10-20 points for 5weeks. Levels prior to vaccine 105-125 with medication. Five weeks after vaccine levels rose to 135-150 gradually returned to previous levels. A1c prior to vaccine 6.3 two months after vaccine 6.8.
Fever after immunisations. No swelling or irritation. Cold SX's at time of visit.
Syncope and Collapse 11-3-21 Driving car and felt surge sensation from both sides of head to top of head with Blue Color. Lasted only seconds before passing out Recovered within 20 seconds
the first 2 days had the expected fever, body aches.  Day 3 and onward started experiencing new and building symptoms as each day progressed.  Headache for 3 days (above right eye, caused some vision changes), then sore throat, cough, brain fog, difficulty sleeping, along with body aches continuing.  Currently on day 13 and still have sore throat, coughing, brain fog, difficulty sleeping, muscle aches, congestion.  Also on day 3, eczema has been building on my face/neck.  Eczema has continued to get worse each day.  when I got the shot, I communicated to the nurse, I was maybe pregnant.  it was too soon to test.  That was Friday.  I had a positive pregnancy test the following Tuesday.  I've since taken 2 more tests that were positive and have missed my period.  So safe to say i'm pregnant.
Fussy inconsolable crying for 4 hrs p/DTP given (w/in first 24 hrs post DTP);
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient).  A 60-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had pcr positive/tested positive in Jan2021 with outcome of unknown. She specified doing her test an hour and a half after vaccination. She then described doing two additional PCR tests, one that same night and the other the next day, and both came out negative. She added she "had no symptoms from the shot". She asked if the COVID-19 vaccine can cause a false positive PCR test.  Information about lot/batch number has been requested.
Sore arm; altered mental status; Anomic Aphasia; short term memory loss; This case was reported by a consumer via call center representative and described the occurrence of mental status changes in a 66-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 9ZK5T, expiry date 7th October 2024) for prophylaxis.   On 26th September 2022, the patient received Boostrix. On 26th September 2022, less than a day after receiving Boostrix, the patient experienced mental status changes, aphasia and short-term memory loss. On 29th September 2022, the patient experienced pain in arm. On an unknown date, the outcome of the mental status changes, aphasia and short-term memory loss were unknown and the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the mental status changes, aphasia, short-term memory loss and pain in arm to be related to Boostrix.     Additional Information: GSK Receipt Date: 07-OCT-2022 Reporter's Comment: The reporter stated that the patient received a dose of Boostrix and then experienced a sore arm for 2 to 3 days, altered mental status, anomic aphasia, and short term memory loss. The reporter consented to follow. Additional supportive information: As the onset date of event pain in arm was reported before administration of vaccine, however it was captured as 29 Sep 2022 conservatively
Day after 2nd dose. Temperature over 100 all day. Tylenol did not help. Bad muscle aches. Headache. Fatigue. 2nd day after totally fine. 3rd day after. Fatigue. Headache. Heart palpitations. High blood pressure. Racing heart. Day 4 after. Heart attack symptoms. Severe anxiety. Dizzy. Neck and jaw pain. Severe Chest pain. Upset stomach. High blood pressure. Racing heart.
INTENSE SHIVERING X 3HRS HEADACHE POSSIBLE FEVER ELEVATED PULSE AROUND 100 (MY NORMAL 70'S) COULD NOT GET WARM GI SYMPTOMS
area of redness and swelling starting 3 hours after injection, continuing to spread to area 4" by 4" on 8/4/2021, upper area had hard lump 1/4" by 1 " on 8/3/21 that decreased in size by 8/4/21.  started taking oral benadryl evening of 8/3/21 but redness area continued to increase in size from 2" by 2" on 8/3/21 to 4" by 4" on 8/4/21. she returned to the pharmacy 8/3/21 and showed area and returned again on 8/4/21.
form read child needed Tdap,  later review of records showed it was 2nd dose and Td would be correct vaccine
Two days post vax the pt experienced a rash on her arms, legs, trunk and neck lasting two hours. She also experienced some heartburn chest pain at base of sternum radiating to left and right. The chest pain had no accompanying shortness of breath, weakness or nausea. It did not increase with activity. Some pain did extend up into jaw. At office visit, pt had dull epigastric pain without other signs or symptoms. The rash was totally resolved. No sensation of throat closing. The decision was made to go ahead with the next immunization, when due. The most recent information received reports the condition of the pt is unknown.
Patient was given 0.25 mL instead of 0.5 mL, had to come back and receive another 0.25 mL the same day
Hives ongoing since vaccine - taking Zyrtec, Prednisone, Pepcid, Benadryl
Completed consult regarding patient's hospitalization due to broken leg. Pt received 2nd Moderna COVID 19 vaccine on March 12th Lot#048A1A and felt different the next few days and wobbly/off balance which is not usual for her.  She does walk with a walker but is normally well balanced.  She fell March 14, 2021 and her left got caught under the sofa and she broke her leg. Pt wanted to make a report to CDC to let them know how she felt the day she broke her leg. She was hospitalized from 3/14/21 to 4/26/2021 which included her care in subacute care.  Her 1st dose of Moderna was on Feb 12, 2021 Lot#011M20A.  Reported to VAERS and patient is doing well and recovering.
Patient comes in 10/23/2010 at 930am with the red spot (about 2 inches diameters) at injection site, swelling, tender to touch, feeling warm around red spot and complained itching.
Intense vertigo with nausea and nystagmus started 3 days after injection (1/30).  Couldn't walk or stand so went to  Emergency Room on 1/31.  MRI of head & neck done to rule out stroke.   Meclizine 25mg & ondansetron 4mg ODT prescribed.  Meclizine 25mg x 2-3 doses per day was needed for the next 7 days to perform daily activity.  Was able to resume walking slowly with medication on 2/1, but could not look at a computer screen to work without meclizine due to nystagmus until 2/6.  Symptoms did not improve enough to be cleared to drive until 2/9.  Full symptom resolution by 2/11.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a consumer by a Other company (Pfizer Inc.) concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergy. The patient previously received first dose of covid-19 vaccine ad26.cov2.s (dose number in series 1) (unspecified manufacturer) (suspension for injection, route of admin not reported, batch number: unknown, expiry: UNKNOWN) dose, therapy start dates were not reported, 1 in total administered for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (dose number in series 1).  The patient additionally received second dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855835, expiry: UNKNOWN) dose was not reported, 1 in total administered on 07-MAR-2022 for covid-19 prophylaxis. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient reported that, the initial symptoms began on 08-MAY-2023 mid day, test was performed which showed negative covid-19 home test. On 09-MAY-2023, 06:00 the symptoms increased (sore throat, cough, hoarseness, malaise), with the positive covid-19 home test (dose number in series 2). The patient was treated with Non-company suspect drugs included: nirmatrelvir/ritonavir (form of admin, route of admin, and batch number were not reported) dose and frequency were not reported from 09-MAY-2023 at 08:00 to 13-MAY-2023 for treatment of covid-19. The patient took as instructed for 5 days. No concomitant medications were reported.  On 13-MAY-2023, covid-19 home test was performed which gave negative result. Symptoms had resolved. On 18-MAY-2023 20:00, the patient experienced burning sensation in the nose and slight cough returned. On 19-MAY-2023, full return of covid-19 symptoms (frequent cough, hoarseness, malaise, burning sensation in the nose, sore throat) and covid-19 home test was performed which gave positive result (confirmed covid-19 infection) which led to confirmed clinical vaccination failure (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with nirmatrelvir/ritonavir was not reported. The patient was recovering from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint, and reference number requested.; Sender's Comments: V0: 20230563383-confirmed clinical vaccination failure . The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
This spontaneous report was received from an unspecified source via published article referring to a 900 unspecified children of unknown age and gender. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was provided. On an unknown dates, the patients were vaccinated with a dose of ROTATEQ orally (strength, dose number, frequency, lot number and expiration date were not provided)  for prophylaxis, through a free or low-cost vaccine program. It was reported that during a routine compliance visit, problems with refrigeration temperatures were discovered. Also, it was reported that the vaccines were not stored properly at the right temperatures, which possibly reduced their effectiveness and the temperature problems may had occurred as early as November 2014. The children who should be evaluated for revaccination were vaccinated between November 2014 and 28-JUL-2016. Additionally, it was reported that the possible ineffective vaccines did not pose any health dangers to the children who received them but those children may not be fully protected against vaccine-preventable diseases. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA005965: US-009507513-1701USA005969: US-009507513-1701USA005967: US-009507513-1701USA005968: US-009507513-1701USA004881: US-009507513-1701USA005966:
Info has been received from an CMA concerning a 7 year old male with no medical history or allergies who on 1/14/00 was vaccinated, SC, with a 0.5 mL dose of varicella virus vaccine live (lot 632042/1360J). There was no concomitant therapy. The CMA reported that on 1/23/06, the pt broke out in a diffuse "pox-like" rash. No fever or other symptoms were noted. Unspecified medical attention was sought, but no treatment or lab/diagnostic testing was required. At the time of this report, the pt was recovering from his "pox-like" rash. Additional info has been requested.
Information has been received from a medical assistant concerning a 6 year old female who on 29-JUL-2008 was vaccinated with ZOSTAVAX (Merck).  No adverse event was reported.  Follow up information has been received from the medical assistant, who reported that the reason for the confusion was that both vaccines were stored in the same freezer and that the packaging looked very similar.  It was an error of hers not to check twice and make sure that she was administering the correct vaccine.  Follow-up information was received which reported that the patient did not have adverse experience, was scheduled to received VARIVAX (Merck) and was administered ZOSTAVAX (Merck) MSD in error.
About 5 minutes after receiving the vaccine, my throat started feeling dry, scratchy, tight/mildly closed up. It was mild, so I just waited it out. At home about 2-3 hours later my mouth felt dry still and my tongue felt mildly swollen. All very mild, breathing and talking normally so I did not seek treatment. But still seemed like a mild allergic reaction.
17 year old received moderna vaccine; A spontaneous report was received from a pharmacist regarding a 17-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) with inappropriate age at vaccination administration.  The patient's medical history was not included. Concomitant medications were not provided.   On 16 Feb 2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Lot number: 016M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 16 Feb 2021, it was noticed after the vaccine was given that the patient was not the correct age to receive the vaccine. Her age is reported as 17.  No side effects were reported and treatment was not given.  Action taken with mRNA-1273 was not reported.  The outcome of the event, receiving the vaccine at an inappropriate age, was considered resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273.  There were no reported adverse events associated with this case.
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 107) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of 107) and CHILLS (chills). At the time of the report, PYREXIA (fever of 107) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature (107-Unknown):.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
Pt developed red, hot, swollen 8x7cm area to left deltoid within 2 days of MMR. TX'd for cellulitis with Augmentin. 8/14 erythema and swelling resolved.
Fever, chills, extreme fatigue, inability to stand or walk unassisted for several hours, severe headache
High blood pressure / after the vaccine it has been hitting 200/105; Hurts; Feel horrible; Bad headaches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure / after the vaccine it has been hitting 200/105), PAIN (Hurts), FEELING ABNORMAL (Feel horrible) and HEADACHE (Bad headaches) in a 54-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     Patient had no past medical history of any allergies and neither tested positive for covid test or diagnosis.  The patient's past medical history included Heart disorder (even before the moderna vaccine and had underlying issues). Concomitant products included CARVEDILOL and IVABRADINE HYDROCHLORIDE (CORLANOR) for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (High blood pressure / after the vaccine it has been hitting 200/105), PAIN (Hurts), FEELING ABNORMAL (Feel horrible) and HEADACHE (Bad headaches). At the time of the report, HYPERTENSION (High blood pressure / after the vaccine it has been hitting 200/105), PAIN (Hurts), FEELING ABNORMAL (Feel horrible) and HEADACHE (Bad headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 108/64 for many years even before the moderna vaccine and 200/105 after the vaccine and believed it was the vaccine.         Concomitant medications also included bunch of medications, nitro patches to lower blood pressure.  Patient had no past medical history of any allergies and neither tested positive for covid test or diagnosis.The patient stated that he had been trying to get the blood pressure down and stated that the medications had not helped a lot. The blood pressure had been too high and stated that he did not want the vaccine to stay in his body for the rest of his life.  The patient reported for underlying issues and received both doses in the recommended time frame.  No treatment medications were reported.
A non-serious spontaneous report of irritability, eye swelling, fever, congestion, runny nose, and cough has been received from a consumer/mother concerning her five-year-old daughter, subsequent to FLUMIST. The patient's medical history and concurrent medications were not reported. On 01-Oct-2009, the patient received FLUMIST. On 03-Oct-2009, the child experienced sudden irritability, eye swelling, congestion, runny nose and cough. The mother reported that her daughter is "doing better."
I started feeling like I was having a really bad cold on 1APR23 like it was at the back of my throat and having a dry cough. I felt like I had no energy and was tired from coughing all night. I sent a message via the online portal to my doctor sometime on the 3APR23. She prescribed PAXLOVID on 5APR23 and to stop simvastatin.
patient experienced a migraine, legs became so painful he could not get out of bed.  He had a fever, congestion, runny nose.  He went to the hospital and was diagnosed initially with an upper respiratory virus.  Another physician attributed his symptoms to the Pfizer covid vaccine.
swelling under L/R arm; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 intramuscular, administered in Arm Right on 20Jan2021 (Batch/Lot Number: EJ1686) as DOSE 2, SINGLE; dose 3 intramuscular, administered in Arm Right on 01Oct2021 (Batch/Lot Number: FC3182) as DOSE 3 (BOOSTER), SINGLE  for covid-19 immunisation. Medical history included ongoing seasonal allergy, ongoing osteoporosis. Concomitant medications included cetirizine hydrochloride (ZYRTEC) taken for seasonal allergy from an unspecified start date and ongoing; colecalciferol (VITAMIN D) taken for osteoporosis from an unspecified start date and ongoing. Historical vaccine included BNT162B2 on 29Dec2020 for COVID-19 immunization, 1st dose; Anatomical location: Left arm; Route of administration: Intramuscular; Batch/Lot number: EL1284. The patient experienced Swelling under L/R arm, more so on the right, since last 2 vaccinations were in right arm, some swelling remain under both arms on 25Jan2021 and 10OCt2021. No treatment given, outcome of the event was recovering. Seriousness Criteria: Important Medical Event as per reporter. AE required visit to Physician office.  Follow-up attempts are completed. No further information is expected.
Extreme chills; Extreme shaking; Headache; Weakness; Off label use/ Dose number: 3; Dose number 3; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an unspecified route of administration in the right arm on 30Sep2021 at 10:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation ( A fib) and known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 30Sep2021 at 22:00, the patient experienced extreme chills and shaking, headache and weakness. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme chills and shaking, headache and weakness was unknown at the time of this report.
Patient received her 1st dose of the COVID 19 vaccine on 12/30/2020. She woke up on 1/8/2021 with a red, swollen, itchy, and hot left arm. She resumed taking her usual prescribed medications and went to her PCP on 1/11/2021. Her PCP informed her that it was a reaction to the COVID 19 vaccine. The patient has not taken any further action for her reaction to the COVID 19 vaccine.
Information has been received from a registered nurse concerning a 6 year old female patient who on 11/08/95 was vaccinated with one dose of Varicella virus vaccine live. There was no concomitant therapy. On 03/31/00, the patient presented to a physician's office with varicella lesions all over her body. The patient's experience was considered to be disabling by the reporter. No prescription drug treatment was required for the experience. Follow-up information from a registered nurse reported that all of the patient's lesions were scabbed over and no other problems were noted. Another patient (WAES #00061355) had a similar experience.
Reduced movement in right leg for 10 days. Slight swelling above right knee; no fever. Rx Tylenol and cool compresses. Admitted to hospital for evaluation day #7--CBC NL, Sedimentary Rate 24. MRI--myositis and small right knee effusion(reactive arthritis). Rx Ancet.
Body aches, skin hurt to touch over whole body, swelling of right  arm that continues to grow and itch and is hot still on 3rd day
Case number PHEH2014US022458, is an initial spontaneous report from a pharmacist received on 05 Nov 2014. This report refers to a 55-year-old female patient. Medical history and concomitant medications were not reported. The patient received two doses of FLUVIRIN (batch number: not available) intramuscularly on the morning of 05 Nov 2014 at the hospital. No adverse event was reported following this medication error.
11/7 - onset red, induration (L) deltoid 2 days after HPV.